OBJECTIVE: It has not been established whether nocturnal nondipping of heart rate (HR) predicts future cardiovascular disease (CVD). We performed this study to test the hypothesis that nocturnal nondipping of HR predicts the risk of incident CVD independent of nocturnal blood pressure dipping pattern. METHODS: Ambulatory blood pressure monitoring was performed in 457 uncomplicated patients, who were being treated or evaluated for hypertension. They were followed for an average of 72 +/- 26 months. Nondipping HR was defined as a night/day HR ratio greater than 0.90. We chose two outcomes for this analysis: CVD events (defined as stroke, myocardial infarction, or sudden cardiac death) and all-cause mortality. Cox regression analyses (stepwise method) were used to estimate hazard ratios and their 95% confidence interval after adjusting for covariates. RESULTS: In univariate analysis, increased sleep HR and nondipping of HR were associated with increased risk of CVD and all-cause mortality, but awake HR was not. In multivariable analyses, HR nondipping status significantly predicted an increased risk of CVD events (hazard ratio, 2.37; 95% confidence interval, 1.22-4.62; P = 0.01), but not for all-cause mortality. Increased 24-h HR was significantly associated with increased risk of all-cause mortality (hazard ratio, 1.67; 95% confidence interval, 1.11-2.51; P = 0.01). CONCLUSION: The risk of future CVD was shown to be 2.4 times higher in those whose HR does not exhibit the typical nocturnal decline. The relationship was independent of nondipping of SBP and was not dependent on diabetes status or blood pressure level.
OBJECTIVE: It has not been established whether nocturnal nondipping of heart rate (HR) predicts future cardiovascular disease (CVD). We performed this study to test the hypothesis that nocturnal nondipping of HR predicts the risk of incident CVD independent of nocturnal blood pressure dipping pattern. METHODS: Ambulatory blood pressure monitoring was performed in 457 uncomplicated patients, who were being treated or evaluated for hypertension. They were followed for an average of 72 +/- 26 months. Nondipping HR was defined as a night/day HR ratio greater than 0.90. We chose two outcomes for this analysis: CVD events (defined as stroke, myocardial infarction, or sudden cardiac death) and all-cause mortality. Cox regression analyses (stepwise method) were used to estimate hazard ratios and their 95% confidence interval after adjusting for covariates. RESULTS: In univariate analysis, increased sleep HR and nondipping of HR were associated with increased risk of CVD and all-cause mortality, but awake HR was not. In multivariable analyses, HR nondipping status significantly predicted an increased risk of CVD events (hazard ratio, 2.37; 95% confidence interval, 1.22-4.62; P = 0.01), but not for all-cause mortality. Increased 24-h HR was significantly associated with increased risk of all-cause mortality (hazard ratio, 1.67; 95% confidence interval, 1.11-2.51; P = 0.01). CONCLUSION: The risk of future CVD was shown to be 2.4 times higher in those whose HR does not exhibit the typical nocturnal decline. The relationship was independent of nondipping of SBP and was not dependent on diabetes status or blood pressure level.
Authors: P Greenland; M L Daviglus; A R Dyer; K Liu; C F Huang; J J Goldberger; J Stamler Journal: Am J Epidemiol Date: 1999-05-01 Impact factor: 4.897
Authors: J A Staessen; L Thijs; R Fagard; E T O'Brien; D Clement; P W de Leeuw; G Mancia; C Nachev; P Palatini; G Parati; J Tuomilehto; J Webster Journal: JAMA Date: 1999-08-11 Impact factor: 56.272
Authors: K Kario; K Motai; T Mitsuhashi; T Suzuki; Y Nakagawa; U Ikeda; T Matsuo; T Nakayama; K Shimada Journal: Hypertension Date: 1997-12 Impact factor: 10.190
Authors: P Verdecchia; C Porcellati; G Schillaci; C Borgioni; A Ciucci; M Battistelli; M Guerrieri; C Gatteschi; I Zampi; A Santucci; C Santucci; G Reboldi Journal: Hypertension Date: 1994-12 Impact factor: 10.190
Authors: P Verdecchia; G Schillaci; C Borgioni; A Ciucci; M P Telera; S Pede; R Gattobigio; C Porcellati Journal: J Hypertens Date: 1998-09 Impact factor: 4.844
Authors: Fadi Seif; Sanjay R Patel; Harneet K Walia; Michael Rueschman; Deepak L Bhatt; Roger S Blumenthal; Stuart F Quan; Daniel J Gottlieb; Eldrin F Lewis; Susheel P Patil; Naresh M Punjabi; Denise C Babineau; Susan Redline; Reena Mehra Journal: J Hypertens Date: 2014-02 Impact factor: 4.844
Authors: Megan S Johnson; Vincent G DeMarco; Cheryl M Heesch; Adam T Whaley-Connell; Rebecca I Schneider; Nathan T Rehmer; Roger D Tilmon; Carlos M Ferrario; James R Sowers Journal: Am J Physiol Heart Circ Physiol Date: 2011-08-05 Impact factor: 4.733
Authors: Winfried Rief; Paul J Mills; Sonia Ancoli-Israel; Michael G Ziegler; Meredith A Pung; Joel E Dimsdale Journal: Psychosom Med Date: 2010-09-14 Impact factor: 4.312